Evaluating the utility of a two‐assay serological algorithm for hepatitis C screening in a low prevalence population
Open Access
- 27 April 2023
- journal article
- research article
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 37 (7) , e24887
Abstract
Introduction: Screening for hepatitis C virus (HCV) is performed by testing for anti‐HCV antibodies, which may yield false‐positive results leading to additional testing and other downstream consequences for the patient. We report our experience in a low prevalence population (<0.05%) using a two‐assay algorithm aimed at testing specimens with borderline or weak positive anti‐HCV reactivity in the screening assay by a second anti‐HCV assay prior to confirming positive anti‐HCV results with RT‐PCR.Materials and Methods: Retrospective analysis of 58,908 plasma samples was obtained over a 5‐year period. Samples were initially tested using the Elecsys Anti‐HCV II assay (Roche Diagnostics), with borderline or weakly positive results (defined in our algorithm as a Roche cutoff index of 0.9–19.99) reflexively analyzed using the Architect Anti‐HCV assay (Abbott Diagnostics). The Abbott anti‐HCV results dictated the final anti‐HCV interpretation for reflexed samples.Results: Our testing algorithm resulted in 180 samples requiring second‐line testing, with final anti‐HCV results interpreted as 9% positive, 87% negative, and 4% indeterminate. The positive predictive value (PPV) of a weakly positive Roche result was 12%, which was significantly lower than the PPV using our two‐assay approach (65%).Conclusions: The incorporation of a two‐assay serological testing algorithm in a low prevalence population provides a cost‐effective method of improving the PPV of HCV screening in specimens with borderline or weakly positive anti‐HCV results.Keywords
This publication has 16 references indexed in Scilit:
- Hepatitis C virus infection spontaneous clearance: Has it been underestimated?International Journal of Infectious Diseases, 2018
- Increases in Acute Hepatitis C Virus Infection Related to a Growing Opioid Epidemic and Associated Injection Drug Use, United States, 2004 to 2014American Journal of Public Health, 2018
- One or two serological assay testing strategy for diagnosis of HBV and HCV infection? The use of predictive modellingBMC Infectious Diseases, 2017
- Retrospective analysis on the diagnostic performances and signal‐to‐cut‐off ratios of the Elecsys Anti‐HCV II assayJournal of Clinical Laboratory Analysis, 2017
- Comparison of Elecsys Anti-HCV II Assay With Other HCV Screening AssaysJournal of Clinical Laboratory Analysis, 2015
- Comparison of Serial Hepatitis C Virus Detection in Samples Submitted through Serology for Reflex Confirmation versus Samples Directly Submitted for QuantitationJournal of Clinical Microbiology, 2011
- Prevention of Hepatitis B Virus and Hepatitis C Virus Transmission in Hemodialysis Centers: Review of Current International RecommendationsArab Journal of Nephrology and Transplantation, 2011
- Cost-effective analysis of different algorithms for the diagnosis of hepatitis C virus infectionBrazilian Journal of Medical and Biological Research, 2008
- Natural History of Hepatitis CClinics in Liver Disease, 2005
- Quantitative signal of anti-HCV by an automated assay predicts viremia in a population at high prevalence of hepatitis C virus infectionJournal of Clinical Virology, 2004